Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.
about
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisHMG CoA reductase inhibitors (statins) for dialysis patientsHMG CoA reductase inhibitors (statins) for dialysis patientsHMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisStatins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trialsEfficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortalityEffect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic reviewProspective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.Statin use is not associated with reduced risk of skin cancer: a meta-analysis.Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy.Dyslipidemia in children with CKD: should we treat with statins?Statins, inflammation and kidney disease.Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials.Sources of Mortality on Dialysis with an Emphasis on Microemboli.Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patientsEffectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis
P2860
Q24194514-7BC8A2F0-BF4F-4D54-8B50-B18CD902FEC9Q24198108-A073D1F9-8F09-4708-A6B5-7CD865A20A86Q24239881-2795F5DD-43C3-4F61-9056-FEE9976F0229Q24241472-10CADA46-D2FF-4452-8A3F-4333A6D0A141Q34086279-3E5F165E-414E-4321-A705-2A2FC377DE58Q34142678-23580F30-22AD-4142-9674-4976BB736E20Q34409791-7F64025A-6A40-4A61-9E67-2DECB038D605Q34531972-6E28B96A-70C1-4C5C-B011-59702A0AD342Q34613884-FDCF49D3-6BE5-4829-9148-5FFFF246ED36Q36265484-62165892-2AEA-45E7-831E-1C6D452BE5BAQ37237515-774E9372-A9F8-4E5E-BB00-59838DE218E9Q37559024-E551C496-E7A3-470D-929A-5918C79CC484Q37638675-A0BCBFB0-3867-4EED-9A09-4634DDCE6C1EQ37704388-A2EE0C94-F8AE-4165-88A3-32ED0B770C92Q37864579-61AFD064-ADAA-4A6B-BAE3-B00A403BA842Q37883015-7E9FE536-7E6E-416C-84D2-5EE97D6C46CDQ37981596-51158068-E1E7-4B52-BAE5-0815CB892DCBQ38928458-2D4FD398-34CB-4323-AC0D-C238257C5DDBQ57220223-BBDC9575-1F16-4B91-A7F9-26A00C785A91Q59127199-4B6E99D7-48F0-4CA4-8878-CA2A93551F73
P2860
Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@en
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@nl
type
label
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@en
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@nl
prefLabel
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@en
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@nl
P2093
P2860
P1476
Low-dose atorvastatin in sever ...... ed, controlled endpoint study.
@en
P2093
A M Wikdahl
B G Stegmayr
B Granroth
B Holmberg
B Isaksson
E Olausson
P2860
P304
P356
10.1080/00365590500329304
P577
2005-01-01T00:00:00Z